Smart portfolio: Top 8 stock bets of Wasatch Emerging India Fund
The Emerging India Fund focuses on identifying quality companies in India. Net assets of the fund as of January 4 stood at $68.1 million.
By Yatin Mota, 
| Updated:
| Updated: 
NEW DELHI: The Wasatch Emerging India Fund, managed by Ajay Krishnan, has generated 9.29 per cent annual returns since its launch in April 2011, outperforming the MSCI India IMI Index, which has lost 1.23 per cent in the same period.
The Emerging India Fund focuses on identifying quality companies in India. Net assets of the fund as of January 4 stood at $68.1 million.
The Emerging India Fund seeks to provide long-term capital appreciation. The fund invests primarily in equities of small companies tied economically to India, Wasatch Funds said in its investment strategy note.
The fund will allow investors to invest in what it believes to be the most compelling opportunities in one of the most rapidly developing countries in the world.
The top ten stocks in their India portfolio include names like - Marksans Pharma, Glenmark Pharma, Natco Pharma, Bajaj Finance, Repco Home Finance, HCL Technologies, Lupin, and Caplin Point Laboratories.
This fund invests primarily in small companies as well as some mid-sized companies with market caps of less than $5 billion at the time of purchase.
As the first actively managed fund focused on smallcaps in India, the fund allows investors to find undiscovered companies tied to the rapidly growing Indian market.
The fund seeks companies with excellent earnings growth, which may also capture PE expansion as their success is more broadly recognised.
Portfolio Manager Ajay Krishnan seeks out the best growth companies in India by looking at various parameters such as high return on capital, market leadership or growing market share and the company’s ability to capitalise on favourable long-term trends.
The company should possess strong financial health and controls, and have reasonable debt use. Expanding operating margins and attractive valuations are some of the parameters Ajay Krishnan looks at before investing in a company.
The Emerging India Fund focuses on identifying quality companies in India. Net assets of the fund as of January 4 stood at $68.1 million.
The Emerging India Fund seeks to provide long-term capital appreciation. The fund invests primarily in equities of small companies tied economically to India, Wasatch Funds said in its investment strategy note.
The fund will allow investors to invest in what it believes to be the most compelling opportunities in one of the most rapidly developing countries in the world.
The top ten stocks in their India portfolio include names like - Marksans Pharma, Glenmark Pharma, Natco Pharma, Bajaj Finance, Repco Home Finance, HCL Technologies, Lupin, and Caplin Point Laboratories.
ADVERTISEMENT
This fund invests primarily in small companies as well as some mid-sized companies with market caps of less than $5 billion at the time of purchase.
As the first actively managed fund focused on smallcaps in India, the fund allows investors to find undiscovered companies tied to the rapidly growing Indian market.
The fund seeks companies with excellent earnings growth, which may also capture PE expansion as their success is more broadly recognised.
ADVERTISEMENT
Portfolio Manager Ajay Krishnan seeks out the best growth companies in India by looking at various parameters such as high return on capital, market leadership or growing market share and the company’s ability to capitalise on favourable long-term trends.
The company should possess strong financial health and controls, and have reasonable debt use. Expanding operating margins and attractive valuations are some of the parameters Ajay Krishnan looks at before investing in a company.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
